Factors associated with the prevalence and incidence of Trichomonas vaginalis infection among African American women in New York city who use drugs

Journal of Infectious Diseases

Volumn 197, Issue 4, 2008, Pages 503-509

  Miller, Maureen ^a   Liao, Yuyan ^b   Gomez, Anu Manchikanti ^c   Gaydos, Charlotte A ^d   D'Mellow, Delysha ^b  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b Mailman School of Public Health   (United States)

^c The University of North Carolina at Chapel Hill   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BACTERIAL TRANSMISSION; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; DRUG USE; FEMALE; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION PREVENTION; MAJOR CLINICAL STUDY; NEISSERIA GONORRHOEAE; PRIORITY JOURNAL; QUESTIONNAIRE; SCREENING; SEROLOGY; SEXUAL BEHAVIOR; TRICHOMONAS VAGINALIS; TRICHOMONIASIS;

ADOLESCENT; ADULT; AFRICAN AMERICANS; ANIMALS; CHLAMYDIA INFECTIONS; COHORT STUDIES; FEMALE; GONORRHEA; HERPES GENITALIS; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; INCIDENCE; MIDDLE AGED; NEW YORK CITY; PREVALENCE; RISK FACTORS; SEXUAL BEHAVIOR; SUBSTANCE-RELATED DISORDERS; TRICHOMONAS VAGINALIS; TRICHOMONAS VAGINITIS;

EID: 40049097066     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/526497     Document Type: Article

References (40)

1. Cates W Jr. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel. Sex Transm Dis 1999; 26:S2-7.
2. Schwebke JR, Burgess D. Trichomoniasis. Clin Microbiol Rev 2004; 17:794-803.
3. Soper D. Trichomoniasis: under control or undercontrolled? Am J Obstet Gynecol 2004; 190:281-90.
4. Van Der Pol B. Trichomonas vaginalis infection: the most prevalent nonviral sexually transmitted infection receives the least public health attention. Clin Infect Dis 2007; 44:23-5.
5. Wendel KA, Erbelding EJ, Gaydos CA, Rompalo AM. Trichomonas vaginalis polymerase chain reaction compared with standard diagnostic and therapeutic protocols for detection and treatment of vaginal trichomoniasis. Clin Infect Dis 2002; 35:576-80.
6. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2006. Available at: http://www.cdc.gov/STD/treatment/2006/ vaginal-discharge.htm#vagdis3. Accessed 20 July 2007.
7. Van Der Pol B, Williams JA, Orr DP, Batteiger BE, Fortenberry JD. Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women. J Infect Dis 2005; 192:2039-44.
8. Weinstock H, Berman S, Cates W Jr. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health 2004; 36:6-10.
9. Fouts AC, Kraus SJ. Trichomonas vaginalis: reevaluation of its clinical presentation and laboratory diagnosis. J Infect Dis 1980; 141:137-43.
10. Cotch MF, Pastorek JG, Nugent RP, et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis 1997; 24:353-60.
11. Minkoff H, Grunebaum AN, Schwarz RH, et al. Risk factors for prematurity and premature rupture of membranes: a prospective study of the vaginal flora in pregnancy. Am J Obstet Gynecol 1984; 150:965-72.
12. Grosskurth H, Mosha F, Todd J, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 1995; 346:530-6.
13. Laga M, Manoka A, Kivuvu M, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 1993; 7:95-102.
14. Wawer MJ, Sewankambo NK, Serwadda D, et al. Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group. Lancet 1999; 353:525-35.
15. Chesson HW, Blandford JM, Pinkerton SD. Estimates of the annual number and cost of new HIV infections among women attributable to trichomoniasis in the United States. Sex Transm Dis 2004; 31:547-51.
16. Sorvillo F, Smith L, Kerndt P, Ash L. Trichomonas vaginalis, HIV, and African-Americans. Emerg Infect Dis 2001; 7:927-32.
17. Center for Disease Control and Prevention. Estimated numbers of cases and rates (per 100,000 population) of AIDS, by race/ethnicity, age category, and sex, 2005-50 states and the District of Columbia. Available at: http://www.cdc.gov/HIV/topics/surveillance/resources/reports/2005report/table5a. htm. Accessed 20 April 2007.
18. Peterman TA, Tian LH, Metcalf CA, et al. High incidence of new sexually transmitted infections in the year following a sexually transmitted infection: a case for rescreening. Ann Intern Med 2006; 145:564-72.
19. Shafir SC, Sorvillo FJ. Viability of Trichomonas vaginalis in urine: epidemiologic and clinical implications. J Clin Microbiol 2006; 44:3787-9.
20. Hardick J, Yang S, Lin S, Duncan D, Gaydos C. Use of the Roche Light-Cycler instrument in a real-time PCR for Trichomonas vaginalis in urine samples from females and males. J Clin Microbiol 2003; 41:5619-22.
21. Madico G, Quinn TC, Rompalo A, McKee KT Jr, Gaydos CA. Diagnosis of Trichomonas vaginalis infection by PCR using vaginal swab samples. J Clin Microbiol 1998; 36:3205-10.
22. Rietmeijer CA, Van Bemmelen R, Judson FN, Douglas JM Jr. Incidence and repeat infection rates of Chlamydia trachomatis among male and female patients in an STD clinic: implications for screening and rescreening. Sex Transm Dis 2002; 29:65-72.
23. Bachmann LH, Lewis I, Allen R, et al. Risk and prevalence of treatable sexually transmitted diseases at a Birmingham substance abuse treatment facility. Am J Public Health 2000; 90:1615-8.
24. Plitt SS, Garfein RS, Gaydos CA, Strathdee SA, Sherman SG, Taha TE. Prevalence and correlates of Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis infections, and bacterial vaginosis among a cohort of young injection drug users in Baltimore, Maryland. Sex Transm Dis 2005; 32:446-53.
25. Shuter J, Bell D, Graham D, Holbrook KA, Bellin EY. Rates of and risk factors for trichomoniasis among pregnant inmates in New York City. Sex Transm Dis 1998; 25:303-7.
26. Sorvillo F, Kovacs A, Kerndt P, Stek A, Muderspach L, Sanchez-Keeland L. Risk factors for trichomoniasis among women with human immunodeficiency virus (HIV) infection at a public clinic in Los Angeles County, California: implications for HIV prevention. Am J Trop Med Hyg 1998; 58:495-500.
27. Khan A, Fortenberry JD, Juliar BE, Tu W, Orr DP, Batteiger BE. The prevalence of chlamydia, gonorrhea, and trichomonas in sexual partnerships: implications for partner notification and treatment. Sex Transm Dis 2005; 32:260-4.
28. Williams KM, Wingood GM, DiClemente RJ, et al. Prevalence and correlates of Chlamydia trachomatis among sexually active African-American adolescent females. Prev Med 2002; 35:593-600.
29. Roche B, Neaigus A, Miller M. Street smarts and urban myths: women, sex work, and the role of storytelling in risk reduction and rationalization. Med Anthropol Q 2005; 19:149-70.
30. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999; 75:3-17.
31. Wasserheit JN. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis 1992; 19:61-77.
32. Niccolai LM, Kopicko JJ, Kassie A, Petros H, Clark RA, Kissinger P. Incidence and predictors of reinfection with Trichomonas vaginalis in HIV-infected women. Sex Transm Dis 2000; 27:284-8.
33. New York City Department of Health and Mental Hygiene. HIV epidemiology program second semiannual report. Available at: http://www.nyc.gov/html/doh/ downloads/pdf/dires/dires-2005-reportsemi2.pdf. Accessed 20 July 2007.
34. Schwebke JR. Update of trichomoniasis. Sex Transm Infect 2002; 78:378-9.
35. Gaydos CA. Rapid tests for sexually transmitted diseases. Curr Infect Dis Rep 2006; 8:115-24.
36. Huppert JS, Mortensen JE, Reed JL, et al. Rapid antigen testing compares favorably with transcription-mediated amplification assay for the detection of Trichomonas vaginalis in young women. Clin Infect Dis 2007; 45:194-8.
37. Gaydos CA, Rompalo AM. The use of urine and self-obtained vaginal swabs for the diagnosis of sexually transmitted diseases. Curr Infect Dis Rep 2002; 4:148-57.
38. Rompalo AM, Gaydos CA, Shah N, et al. Evaluation of use of a single intravaginal swab to detect multiple sexually transmitted infections in active-duty military women. Clin Infect Dis 2001; 33:1455-61.
39. Heckathorn D. Respondent driven sampling: a new approach to the study of hidden populations. Social Probl 1997; 44:174-99. Available at: http://www.respondentdrivensampling.org/reports/RDSI.pdf. Accessed 14 January 2008.
40. Thompson SK, Seber GAF. Adaptive sampling. New York, NY: John Wiley and Sons, 1996.